Funding for this research was provided by:
Paracelsus Medical University
Article History
Received: 22 December 2021
Accepted: 14 March 2022
First Online: 22 April 2022
Conflict of interest
: T. Moser received personal compensations from Biogen Idec, BMS/Celgene, Novartis, Roche, Sanofi, Merck, and Teva. T. Ziemssen received personal compensation from Almirall, Biogen Idec, Bayer, BMS/Celgene, Novartis, Roche, Sanofi Aventis, and Teva for consulting services. His institution received financial support for research activities from Biogen, Novartis, Roche, Teva, and Sanofi Aventis. J. Sellner received honoraria for consultancy or participation in advisory boards from Alexion, BMS/Celgene, Merck, Novartis, Immunic, Roche, Sandoz, and Sanofi Aventis.